PEGylationTIMP2

Jack Toor1, Wiktoria R Grabowska2, Adam L Johnson3

  • 1Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States.

ACS applied bio materials
|February 21, 2025
PubMed
概括

基化增强了治疗性蛋白质的半衰期,例如组织基蛋白酶2抑制剂 (TIMP2). 特定部位的结合改善了TIMP2的药理动力学和稳定性,同时保持了它的活性.